may result from smoking related damage but is not functionally significant. Background -The purpose of this study (Thorax 1997;52:265-270) was to identify morphological differences on the computed tomographic (CT) scan Keywords: lung fibrosis, scleroderma, CT scanning. between cryptogenic fibrosing alveolitis (CFA) and the fibrosing alveolitis asPulmonary complications are now the most sociated with systemic sclerosis (FASSc), frequent cause of death in patients with sysand to examine their biological relevance.
1 cm above the dome of the right hemidiaphragm) a visual assessment was made of the extent of abnormal parenchyma to the nearest 5%. An estimate of overall lung involvement was obtained by combining these and applying a weighting factor to correct for reductions in lung volume in the upper zones. This technique of estimating disease extent has been applied to other interstitial lung conditions 12 and is subject to minor interobserver variation. 13 The mean of the estimates of the two observers was taken. A ratio of upper zone to total lung involvement was derived by dividing the percentage involvement at the carinal level by the sum at this and the basal level (1 cm above the dome of the right hemidiaphragm).
A grading system was used to classify the pattern of lung disease with particular reference to the coarseness of the reticular pattern:
4 grade 0=a predominantly ground glass pattern; grade 1 = fine intralobular fibrosis predominating; grade 2=microcystic pattern with   overt emphysema on the CT scan (emphysema has the potential to affect the apparent zonal Demographic details, smoking history, and pulmonary function indices (expressed as perdistribution and pattern of fibrosing alveolitis 9 ), (2) those with FASSc with obvious end stage centage predicted) were obtained from the hospital case records. The forced vital capacity pulmonary vascular disease out of proportion to the extent of fibrosing alveolitis (severe pul-(FVC), measured with an Ohio water seal spirometer, the carbon monoxide transfer factor monary vascular disease has the potential to affect survival and lung function, independent (T), measured by the single breath technique using a PK Morgan respirometer, and of lung fibrosis), and (3) those with a predominantly ground glass appearance on the arterial oxygen tension in air (Pa 2 ) were used in the analysis. Subjects were classified as CT scan (this pattern of disease has a different natural history 10 and can be regarded as a smokers if they had ever smoked at least one cigarette a day for at least one year. The total separate clinical entity).
The diagnosis of CFA was made by the intake of cigarettes was also recorded in pack years (excluding six patients without a detailed presence of (1) persistent bilateral crackles on auscultation, (2) a restrictive defect or isolated smoking history).
Clinical records and/or death certificates depression of total gas transfer on pulmonary function testing, and (3) the absence of other collected from the National Health Central Registrar were examined to obtain survival causes of pulmonary fibrosis. Patients with FASSc were included provided that they met information to 31 October 1990. In 95 of 107 cases a date of death was established or follow the diagnostic criteria of the American Rheumatological Association for Systemic Sclerosis 11 up information was available on or after 31 October 1990. and had evidence of fibrosing alveolitis by the above criteria.
 
Results are stated as means with standard de-  ()  All CT scans were performed on an Elscint viations. A p value of <0.05 was taken to indicate statistical significance. Group com-2002 scanner (Elscint, Haifa, Israel) with a scanning time of 5.5 seconds. Sections 3 mm parisons were made using the Student's t test or, when appropriate, non-parametric analysis in thickness were taken at 10 mm intervals and reconstructed with a high spatial resolution ( 2 statistics or Wilcoxon's rank sum test). Multivariate analyses were performed using STATA reconstruction algorithm. Sections were obtained at 20 mm intervals through the lower software (STATA Computing Resource Center, Santa Monica, USA). zones with the patient in the prone position to clarify the effects of gravity in the posterobasal Multivariate models 14 were used to determine whether the distribution and pattern of segments of the lower lobes. Window settings were optimised for the lung parenchyma.
disease on the CT scans (examined as dependent variables in separate equations) were All CT sections were examined by two chest radiologists who were not aware of any clinical independently related to the extent of disease on the scans, the type of fibrosing alveolitis, information. At each of five levels (the origin of the great vessels, mid-arch of the aorta, age, sex, and smoking history. The distribution of disease was evaluated using stepwise forward carina, pulmonary venous confluence, and group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from regression; the coarseness of a reticular pattern (which was graded ordinally) was subjected to by the pattern and distribution of disease on the CT scans independent of the extent of fibrosing alveolitis, the type of fibrosing al-(40.4 (8.4)% versus 30.5 (13.0)%, p<0.001). veolitis (CFA versus FASSc), age, sex, and
There was a greater prevalence of coarse resmoking history. In the analysis of survival a ticular disease (grades 3 and 4) in patients with proportional hazards model was used to CFA than in those with FASSc (p<0.001). identify the independent determinants of morOn multivariate analysis ( diseases -the possibility that differences are not related to the specific disease but result from differing referral criteria. Patients with CFA were symptomatic at presentation and variate analyses were repeated in 51 "ever" smokers and 56 lifelong non-smokers. In were referred, in some cases, with progressive disease. Although patients with FASSc were smokers an increasingly coarse reticular pattern was associated with more extensive disease also referred with known or suspected lung fibrosis, the associated systemic disease had (p<0.001) and with a diagnosis of CFA (p<0.02); upper zone involvement increased in served to alert referring physicians to the likelihood of interstitial lung disease. Conassociation with a diagnosis of CFA (p<0.0005) but was unrelated to disease extent. By con-sequently, it was possible that the observed morphological differences were merely a functrast, in non-smokers the coarseness of a reticular pattern and degree of upper zone tion of more extensive or more inherently progressive fibrosing alveolitis in a subgroup of involvement did not differ independently between patients with CFA or FASSc, but in-patients with CFA referred to our institution, and not true properties of that disease. creased with more extensive disease (p<0.01 and p<0.05, respectively).
The problem of matching populations morphologically can now be overcome in interstitial When analyses were repeated, substituting "pack year" smoking histories for "ever/never" lung disease. The extent of disease on the CT scan, scored semiquantitatively, has minor smoking histories, the same trends were observed. The coarseness of a reticular pattern observer variation 13 compared with the considerable observer variation seen in grading was related independently to the extent of disease on the CT scan (increase in reticular score histological features. 15 Moreover, unlike open lung biopsy specimens, CT scanning provides per percentage increase in disease extent= 0.06, 95% confidence interval (CI) 0.03 to a global assessment of the lung. It also avoids the major drawback of using functional indices 0.09, p<0.0005). Increasing upper zone involvement was seen with more extensive disease to control for disease extent -the confounding influence on lung function of concurrent res-(increase in upper zone ratio per percentage increase in disease extent=0.002, 95% CI piratory disease (such as airflow obstruction or pulmonary vascular disease in FASSc). The 0.001 to 0.004, p<0.005) and in patients with CFA (increase=0.07, 95% CI 0.01 to 0.12, use of CT scanning to control for disease extent enabled us to show that the anecdotal obp<0.04).
servation of a coarser reticular pattern in patients with CFA, confirmed on unadjusted analysis, was no longer statistically significant         once overall disease extent was taken into account. The severity of functional impairment, as judged by T, FVC, and resting Pa 2 levels, The problem of matching populations for inherent progressiveness of disease, inwas examined in relation to the extent, distribution, and pattern of disease on the CT dependently of extent, is less straightforward and may be insoluble if diseases differ markedly scan, age, sex, smoking history, and type of fibrosing alveolitis. In separate models, de-in their treated course and natural history. In all published studies CFA has been inexorably pression of T and FVC, but not Pa 2 , were positively related to the extent of disease on progressive with a five year survival of only 50% from the onset of dyspnoea. 8 16 17 By contrast, the CT scan (p<0.0005, p<0.0005, and p= 0.13, respectively). There were no independent despite a histological appearance identical to CFA, 3 lung fibrosis in systemic sclerosis is often relationships between functional indices and the pattern or distribution of disease on the a "hit and run" phenomenon; the prognosis appears to be good except when there is super-CT scan.
Survival was examined using proportional vening pulmonary vascular disease. A comparison of survival between CFA and FASSc, hazards analysis. A diagnosis of CFA (hazards ratio 12.00, 95% CI 2.38 to 60.3, p<0.003) including the matching of a large number of lung function indices, has established that even and more extensive disease on the CT scan group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from patients with FASSc with severe functional of the upper lung zones to smoking related damage; morphologic differences between CFA impairment typical of CFA are not characterised by a CFA-like course.
8 This con-and FASSc were confined to smokers, suggesting that pathogenetic mechanisms in CFA, clusion is reinforced by the absence of reports in the literature of patients with progressive but not in FASSc, might be modulated by smoking. However, the interpretation of these FASSc. However, although matching the rate of disease progression may prove to be un-findings needs to take into account methodological considerations. The use of an "ever/ attainable, the analysis of survival in the present study provides strong indirect evidence that never" smoker dichotomy places heavy smokers and former smokers with a trivial smoking the greater upper zone involvement in CFA is disease-specific. Had this finding been in-history in the same category; by contrast, the use of "pack year" smoking histories fails to dicative merely of more progressive disease in both disorders, and not an intrinsic feature of allow for the fact that the patients most vulnerable to smoking-related damage may be CFA, it should have been independently linked to mortality after adjustment for disease extent more likely to stop smoking earlier in life, obscuring a dose-related effect. Moreover, if in multivariate analysis.
The observation that differences between smoking has differing morphological consequences in different diseases, evidence of CFA and FASSc in the pattern and distribution of disease are minor after adjustment for disease smoking related damage may fail to achieve statistical significance in a combined patient extent and irrelevant to functional impairment and survival has important implications for population (as in our initial multivariate analysis). Finally, the pathogenetic consequences future studies of fibrosing alveolitis. The very different outcome seen in two histologically of smoking in established fibrosing alveolitis may depend solely upon cigarette intake during identical diseases provides an opportunity to gain new pathophysiological insights by iden-disease progression and may not be unmasked with the use of lifelong smoking histories in tifying differences in lung function indices, bronchoalveolar lavage profiles, and other in-analysis. For all these reasons, definitive evidence that smoking influences morphogenesis flammatory markers which may be central to disease progression. However, an accurate in fibrosing alveolitis is probably unattainable from non-longitudinal studies which include means of controlling for disease extent is indispensable if confounding by severity is to be patients with relatively advanced disease.
In conclusion, patients with CFA are charavoided. 18 The present study provides strong support for the future use of a simple semi-acterised by relatively more upper zone involvement on the CT scan than patients with quantitative scoring system of disease extent on the CT scan without the need to control FASSc. However, this finding is functionally irrelevant and is not directly linked to differseparately for the pattern and distribution. Using this methodology we have recently ences in the rate of progression between the two diseases as judged by survival. The extent shown that, for a given disease extent, CFA is characterised by markedly greater arterial of abnormal lung on the CT scan is a suitable means of controlling for disease morphology in hypoxaemia 19 and higher levels of bronchoalveolar eosinophils 20 than are seen in FASSc. future studies of fibrosing alveolitis. In both CFA and FASSc relative increases 
